Immune Responses to AAV in Clinical Trials

Federico Mingozzi, Katherine A. High

Current Gene Therapy

BMP-9 Induced Osteogenic Differentiation of Mesenchymal Stem Cells: Molecular Mechanism and Therapeutic Potential

Gaurav Luther, Eric R. Wagner, Gaohui Zhu, +26

Current Gene Therapy

Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease

Olivier Nègre, Cynthia C. Bartholomae, Yves Beuzard, +21

Current Gene Therapy

miRNA-146a Improves Immunomodulatory Effects of MSC-derived Exosomes in Rheumatoid Arthritis

Fataneh Tavasolian, Ahmad Zavaran Hosseini, Sara Soudi, +1

Current Gene Therapy

Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair

Arash Aghajani Nargesi, Lilach O. Lerman, Alfonso Eirin

Current Gene Therapy

First-in-human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

Françoise Βaylis, Marcus McLeod

Current Gene Therapy

AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success

Angela M. Mitchell, Sarah C. Nicolson, Jayme K. Warischalk, +1

Current Gene Therapy

Adeno-associated VirusComputer-assisted TranslationImmune EvasionGene TherapiesAav Vectors +13

Sodium Chloride Modified Silica Nanoparticles as a Non-Viral Vector with a High Efficiency of DNA Transfer into Cells

Yuxiang Chen, Zhigang Xue, Duo Zheng, +5

Current Gene Therapy

Gene Therapy and Targeted Toxins for Glioma

María G. Castro, Marianela Candolfi, Kurt M. Kroeger, +10

Current Gene Therapy

Neuro-oncologyGene TherapiesDrug TargetingNovel TherapyGlioma +11

Biosafety of Adenoviral Vectors

Marinee Chuah, Désiré Collen, Thierry VandenDriessche

Current Gene Therapy

BiochemistryNeurovirologyVector GenomesImmunologyAntiviral Therapy +9